Dr. BreAnna Guan, ND Subheadline A whole-person exploration of how inflammation, endocrine disruptors, metabolic dysfunction, ...

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...

Chronic kidney disease (CKD) affects more than 10% of the global population and is expected to become the fifth leading cause of death worldwide within the next two decades. Perhaps surprisingly, ...

Peptides continue to occupy a persuasive position within contemporary biochemical and molecular investigations.

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study by a team at the Max Planck Institute ...

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...

Signatera™ will be used to identify patients who may be able to delay or defer adjuvant CDK4/6 inhibitor therapy in ...